Literature DB >> 16783535

Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management.

Jane M Simoni1, Ann E Kurth, Cynthia R Pearson, David W Pantalone, Joseph O Merrill, Pamela A Frick.   

Abstract

A review of 77 studies employing self-report measures of antiretroviral adherence published 1/1996 through 8/2004 revealed great variety in adherence assessment item content, format, and response options. Recall periods ranged from 2 to 365 days (mode = 7 days). The most common cutoff for optimal adherence was 100% (21/48 studies, or 44%). In 27 of 34 recall periods (79%), self-reported adherence was associated with adherence as assessed with other indirect measures. Data from 57 of 67 recall periods (84%) indicated self-reported adherence was significantly associated with HIV-1 RNA viral load; in 16 of 26 (62%), it was associated with CD4 count. Clearly, the field would benefit from item standardization and a priori definitions and operationalizations of adherence. We conclude that even brief self-report measures of antiretroviral adherence can be robust, and recommend items and strategies for HIV research and clinical management.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16783535      PMCID: PMC4083461          DOI: 10.1007/s10461-006-9078-6

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  101 in total

1.  Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimens.

Authors:  Maria Paola Trotta; Adriana Ammassari; Alessandro Cozzi-Lepri; Mauro Zaccarelli; Francesco Castelli; Pasquale Narciso; Sara Melzi; Andrea De Luca; Antonella D'Arminio Monforte; Andrea Antinori
Journal:  AIDS       Date:  2003-05-02       Impact factor: 4.177

2.  The detection of non-adherence by self-administered questionnaires can be optimized by protease inhibitor plasma concentration determination.

Authors:  Ségolène Duran; Gilles Peytavin; Patrizia Carrieri; François Raffi; Jean-Luc Ecobichon; Edwige Pereira; Gilles Patrice Cassuto; Bruno Spire; Catherine Leport
Journal:  AIDS       Date:  2003-05-02       Impact factor: 4.177

3.  Factors associated with accurate self-reported adherence to HIV antiretrovirals.

Authors:  Mina Kimmerling; Glenn Wagner; Bonnie Ghosh-Dastidar
Journal:  Int J STD AIDS       Date:  2003-04       Impact factor: 1.359

4.  Determinants of adherence to highly active antiretroviral therapy (HAART) in Chinese HIV/AIDS patients.

Authors:  O W Fong; C F Ho; L Y Fung; F K Lee; W H Tse; C Y Yuen; K P Sin; K H Wong
Journal:  HIV Med       Date:  2003-04       Impact factor: 3.180

5.  Adherence to antiretroviral therapy and persistence of HIV RNA in semen.

Authors:  Paulo F Barroso; Mauro Schechter; Phalguni Gupta; Clarisse Bressan; Antonieta Bomfim; Lee H Harrison
Journal:  J Acquir Immune Defic Syndr       Date:  2003-04-01       Impact factor: 3.731

6.  Adherence to HIV antiretrovirals among persons with serious mental illness.

Authors:  Glenn J Wagner; David E Kanouse; Paul Koegel; Greer Sullivan
Journal:  AIDS Patient Care STDS       Date:  2003-04       Impact factor: 5.078

7.  Medication adherence in patients with HIV infection: a comparison of two measurement methods.

Authors:  K M Melbourne; S M Geletko; S L Brown; C Willey-Lessne; S Chase; A Fisher
Journal:  AIDS Read       Date:  1999-08

8.  Assessment and predictors of antiretroviral adherence in older HIV-infected patients.

Authors:  Anthony K Wutoh; Oluchi Elekwachi; Veronica Clarke-Tasker; Monika Daftary; Nadina J Powell; Gregorina Campusano
Journal:  J Acquir Immune Defic Syndr       Date:  2003-06-01       Impact factor: 3.731

9.  Predictors of antiretroviral adherence as measured by self-report, electronic monitoring, and medication diaries.

Authors:  Glenn J Wagner
Journal:  AIDS Patient Care STDS       Date:  2002-12       Impact factor: 5.078

10.  Self-reported adherence to antiretroviral treatment and degree of sense of coherence in a group of HIV-infected patients.

Authors:  Claes Cederfjäll; Ann Langius-Eklöf; Knut Lidman; Regina Wredling
Journal:  AIDS Patient Care STDS       Date:  2002-12       Impact factor: 5.078

View more
  331 in total

1.  Assessing medication adherence of perinatally HIV-infected children using caregiver interviews.

Authors:  Susannah M Allison; Linda J Koenig; Stephanie L Marhefka; Rosalind J Carter; Elaine J Abrams; Marc Bulterys; Vicki Tepper; Paul E Palumbo; Pamela J Bachanas; John J Farley
Journal:  J Assoc Nurses AIDS Care       Date:  2010-05-07       Impact factor: 1.354

2.  Antiretroviral adherence during pregnancy and postpartum in Latin America.

Authors:  Regis Kreitchmann; D Robert Harris; Fabiana Kakehasi; Jessica E Haberer; Pedro Cahn; Marcelo Losso; Elizabete Teles; Jose H Pilotto; Cristina B Hofer; Jennifer S Read
Journal:  AIDS Patient Care STDS       Date:  2012-06-04       Impact factor: 5.078

3.  Challenges in using mobile phones for collection of antiretroviral therapy adherence data in a resource-limited setting.

Authors:  Jessica E Haberer; Julius Kiwanuka; Denis Nansera; Ira B Wilson; David R Bangsberg
Journal:  AIDS Behav       Date:  2010-12

4.  Benefits of adherence to psychotropic medications on depressive symptoms and antiretroviral medication adherence among men and women living with HIV/AIDS.

Authors:  Dean G Cruess; Seth C Kalichman; Christine Amaral; Connie Swetzes; Chauncey Cherry; Moira O Kalichman
Journal:  Ann Behav Med       Date:  2012-04

Review 5.  A proposal for quality standards for measuring medication adherence in research.

Authors:  Ann Bartley Williams; K Rivet Amico; Carol Bova; Julie A Womack
Journal:  AIDS Behav       Date:  2013-01

6.  Role of the Pharmacist in Caring for Patients with HIV/AIDS: Clinical Practice Guidelines.

Authors:  Alice Tseng; Michelle Foisy; Christine A Hughes; Deborah Kelly; Shanna Chan; Natalie Dayneka; Pierre Giguère; Niamh Higgins; Cara Hills-Nieminen; Jeff Kapler; Charles J L la Porte; Pam Nickel; Laura Park-Wyllie; Carlo Quaia; Linda Robinson; Nancy Sheehan; Shannon Stone; Linda Sulz; Deborah Yoong
Journal:  Can J Hosp Pharm       Date:  2012-03

7.  Two-way text messaging for health behavior change among human immunodeficiency virus-positive individuals.

Authors:  Lynne T Harris; Keren Lehavot; David Huh; Samantha Yard; Michele P Andrasik; Peter J Dunbar; Jane M Simoni
Journal:  Telemed J E Health       Date:  2010-11-18       Impact factor: 3.536

8.  Situational temptation for HIV medication adherence in high-risk youth.

Authors:  Karen E Macdonell; Sylvie Naar-King; Debra A Murphy; Jeffrey T Parsons; Heather Huszti
Journal:  AIDS Patient Care STDS       Date:  2010-12-16       Impact factor: 5.078

9.  The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States.

Authors:  Yuehan Zhang; Tracey E Wilson; Adebola Adedimeji; Daniel Merenstein; Joel Milam; Jennifer Cohen; Mardge Cohen; Elizabeth T Golub
Journal:  AIDS Behav       Date:  2018-03

10.  Adherence to antiretroviral therapy among HIV-infected adults in the United States.

Authors:  Linda Beer; Jacek Skarbinski
Journal:  AIDS Educ Prev       Date:  2014-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.